Cost and outcomes of paediatric antiretroviral treatment in South Africa

AIDS

Volumn 27, Issue 2, 2013, Pages 243-250

  Meyer Rath, Gesine ^a,b   Brennan, Alana ^a,b   Long, Lawrence ^b   Ndibongo, Buyiswa ^b   Technau, Karl ^c,d   Moultrie, Harry ^c   Fairlie, Lee ^c   Coovadia, Ashraf ^c,d   Rosen, Sydney ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

antiretroviral therapy; cohort studies; costs; outcomes; paediatrics; South Africa

Indexed keywords

ANTIRETROVIRUS AGENT;

ANTIRETROVIRAL TREATMENT; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4 LYMPHOCYTE PERCENTAGE; CHILD; CHILD CARE; COST; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SOUTH AFRICA; TREATMENT OUTCOME; VIRUS LOAD;

ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HIV INFECTIONS; HUMANS; INFANT; SOUTH AFRICA; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84872386586     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32835a5b92     Document Type: Article

References (16)

1. World Health Organization. Global HIV/AIDS response: epidemic update and health sector progress towards universal access: Progress report 2011. Geneva, Switzerland: WHO; 2011.
2. Department of Health, Republic of South Africa. National strategic plan for HIV/AIDS, tuberculosis and STIs 2011-2016. Pretoria, South Africa: Department of Health: 2011.
3. Ciaranello AL, Chang Y, Margulis AV, Bernstein A, Bassett IV, Losina E. Walensky RP. Effectiveness of paediatric antiretrovir-al therapy in resource-limited settings: a systematic review and meta-analysis. Clin Infect Dis 2009; 49:1915-1927.
4. Bock P, Boulle A, White C, Osler M, Eley B. Provision of antiretroviral therapy to children within the public sector of South Africa. Trans Roy Soc Trop Med Hyg 2008; 102:905-911.
5. Reddi A, Leeper SC, Grobler AC, Geddes R, France KH, Dorse GL, et al. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatr 2007; 7:13.
6. Eley BS, Nuttall J, Davis MA, Smith L, Cowburn C, Buys H et al. Initial experience of a public sector antiretroviral treatment programme for HIV-infected children in Cape Town, South Africa [abstract]. Abstract TuPeB4412, XVth International AIDS Conference; 11-16 July 2004; Bangkok, Thailand; 2004.
7. Meyers T, Yotebing M, Kuhn L, MoultrieH.Antiretroviral therapy responses among children attending a large public clinic in Soweto, South Africa. Pediatr Infect Dis J 2011; 30:974-979.
8. KIDS-ART-LINC Collaboration. Low risk of death, but substantial program attrition, in paediatric HIV treatment cohorts in Sub-Saharan Africa. J Acquir Imm Defic Syndr 2008; 49:523-531.
9. Boulle A, Bock P, Osler M, Cohen K, Channing L, Hilderbrand K, et al. Antiretroviral therapy and early mortality in South Africa. Bull WHO 2008; 86:678-687.
10. Menzies NA, Berruti AA, Berzon R, Filler S, Ferris R, Ellerbrock TV, Blandford JM. The cost of providing comprehensive HIV treatmentinPEPFAR- supportedprograms.AIDS2011;25:1753-1760.
11. Department of Health South Africa. National antiretroviral treatment guidelines 2004. Pretoria, South Africa: Department of Health; 2004.
12. Rosen S, Long L, Sanne I. The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa. Trop Med Int Health 2008; 13:1005-1015.
13. Accounting Standards Board South Africa. Standard of generally recognised accounting practice: property plant and equipment (GRAP 176). Pretoria, South Africa: Accounting Standards Board South Africa; 2004.
14. Johnson LF. Access to antiretroviral treatment in South Africa, 2004-2011. S Afr J HIV Med 2012;13:22-27.
15. Meyer-Rath G, Violari A, Cotton M, Ndibongo B, Brennan A, Long L, et al. The cost of early vs. deferred paediatric anti-retroviral treatment in South Africa: a comparative economic analysis of the first year of the CHER trial [abstract]. Abstract THLBB103. XVIII International AIDS Conference, 18-23 July, Vienna, 2010.
16. World Health Organization. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. 2010 revision. Geneva, Switzerland: World Health Organization; 2010.